Journals / Southern Clinics of Istanbul Eurasia / 2020 / Cilt: 31 - Sayı: 2

Evaluation of Parathyroid Hormone Increase After Parathyroidectomy in Primary Hyperparathyroidism

Primer Hiperparatroidizmde Paratroidektomi Sonrası Paratroid Hormon Yüksekliğinin Değerlendirilmesi

Pages
162–165
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Renal diseases, bone hunger and Vitamin D deficiency should be evaluated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we tried to evaluate retrospectively high levels of parathyroidhormone in patients who received parathyroidectomy due to primary hyperparathyroidismin the light of the literature search.Methods: In this study, 121 patients who underwent surgery for primary hyperparathyroidism between September 2015 and December 2017 were retrospectively evaluated, according to gender, preoperative calcium and PTH levels, postoperative calcium and PTHlevels, diagnosis, histopathological results, type of surgery, follow-up time and recurrence.We excluded patients who were unreachable.Results: Mean age was 54.83±12.56 (26–82).
📊
Key Findings & Data:One hundred three patients were female(85.1%).
💡
Conclusion & Impact:Renal diseases, bone hunger and Vitamin D deficiency should be evaluated.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we tried to evaluate retrospectively high levels of parathyroidhormone in patients who received parathyroidectomy due to primary hyperparathyroidismin the light of the literature search.Methods: In this study, 121 patients who underwent surgery for primary hyperparathyroidism between September 2015 and December 2017 were retrospectively evaluated, according to gender, preoperative calcium and PTH levels, postoperative calcium and PTHlevels, diagnosis, histopathological results, type of surgery, follow-up time and recurrence.We excluded patients who were unreachable.Results: Mean age was 54.83±12.56 (26–82). One hundred three patients were female(85.1%). One hundred nineteen patients were diagnosed (98.4%) as adenoma, whereas twopatients were diagnosed as (1.6%) hyperplasia. According to histopathological results, 103(85.1%) adenoma, four (3.3%) carcinoma, four (3.3%) hyperplasia and 10 (8.2%) adenoma andpapillary carcinoma of the thyroid were found. Preoperative mean PTH value was 301.9±470pg/ml (79-3674 pg/ml). Preoperative mean calcium level was 10.10 mg/dl (10.10 - 13.07mg/dl). Postoperative mean PTH value was 77.2±11.1 pg/ml (6.0- 907 pg/ml). Postperativemean calcium level was 9.38±0.7 mg/dl (6.3- 11.4 mg/dl). Mean value was 9.38±0.7 mg/dl.Mean follow-up time was 18.75±5.4 (8–28) months. Post-operative PTH elevation persistedin 17 (14.8%) patients. Nine (7.4%) of them had chronic kidney failure, three (2.4%) patientssuffered from vitamin D deficiency, and five (4.1%) cases had a recurrence.Conclusion: Primary hyperparathyroidism is a rare disease. In the absence of postoperativePTH decrease and normocalcemic PTH elevation should be considered as well as recurrence. Renal diseases, bone hunger and Vitamin D deficiency should be evaluated.

Özet

Amaç: Bu çalışmanın amacı kliniğimizde primer hiperparatiroidizm nedeni ile paratiroidektomi uygulanan hastalar da yüksek paratiroid hormon (PTH) seviyelerini geriye dönük olarak literatür eşliğinde irdelemek. Gereç ve Yöntem: Eylül 2015, Aralık 2017 arasında kliniğimizde primer hiperparatiroidizm nedeni ile ameliyat edilen ve takip edilen 121 hasta yaş cinsiyet, ameliyat öncesi kalsiyum (Ca) ve PTH seviyeleri, ameliyat sonrası Ca ve PTH seviyeleri, tanı, patoloji sonuçları, yapılan ameliyat, takip süresi, nüks açısından geriye dönük olarak değerlendirildi. Kendilerine ulaşılamayan hastalar çalışmaya alınmadı. Bulgular: Primer hiperparatiroidizm nedeni ile ameliyat edilen hastaların en küçüğü 26 yaşında, en büyüğü 82 yaşında olup yaş ortalaması 54.83±12.56 idi. Bunların 103’ü (%85.1) kadın hasta idi. Klinik tanılarına göre hastaların 119’u (%98.4) adenom, ikisi (%1.6) hiperplazi idi. Patolojik sonuçlarına göre ise 103 hasta (%85.1) adenom, dört hasta (%3.3) karsinom, dört hasta (%3,3) hiperplazi, 10 hasta (%8.2) adenom ve troid papiller karsinoma tanısı aldı. Ameliyat öncesi ortalama PTH seviyeleri 301.9±470 pg/ml (en düşük 79 pg/ml, en yüksek 3674 pg/ml), ortalama Ca seviyesi ise 11.42±0.7 mg/dl (en düşük 10.10 mg/dl, en yüksek 13.07 mg/dl) idi. Ameliyat sonrası ortalama PTH seviyesi 77.2±11.1 pg/ ml (en düşük 6.0 pg/ml, en yüksek 907 pg/ml), ortalama Ca seviyesi ise 9.38±0.7 mg/dl (en düşük 6.3 mg/dl, en yüksek 11.4 mg/dl) idi. Takip süresi minimum sekiz ay, maksimum 28 ay olup ortalama 18.75±5.4 ay idi. Ameliyat sonrası PTH yüksekliği 17 (%14.8) hastada devam etti. Dokuz (%7.4) hastada böbrek yetersizliği (bu hastalarda ameliyat sonrası PTH seviyesi normal olup üç-dört ay sonra yükselme tespit edildi), üç (%2.4) hastada vitamin D eksikliği ve beş (%4.1) hastada da nüks tespit edildi. Sonuç: Pirimer hiperparatiroidizm nadir görülen bir hastalıktır. Ameliyat sonrası PTH seviyesi yüksek olan hastalarda nüks yanında normokalsemik PTH elevasyonu (NPE) ve buna sebep olan renal fonksiyon bozukluğu, kemik açlığı ve vitamin D eksikliği de göz önünde bulundurulmalıdır.

🔖

Cite This Article

KÜNDEŞ, M. F., KÜÇÜK, H. F. (2022). Evaluation of Parathyroid Hormone Increase After Parathyroidectomy in Primary Hyperparathyroidism. Southern Clinics of Istanbul Eurasia, Cilt: 31 - Sayı: 2, 162–165. https://ajindex.com/articles/592823

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002;17:N18–N23
  2. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000;343:1863–75
  3. Glendenning P, Gutteridge DH, Retallack RW, Stuckey BG, Kermode DG, Kent GN. High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria. Aust N Z J Med 1998;28:173–8
  4. Endres DB, Villanueva R, Sharp CF Jr, Singer FR. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism. Clin Chem 1991;37:162–8
  5. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, NozawaUng K, Kim LY, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987;33:1364–7
  6. Silverberg SJ, Shane E, Jacobs TP, Siris ES, Gartenberg F, Seldin D, et al. Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 1990;89:327–34
  7. Pérez-Soto R, Herrera MF. Primary hyperparathyroidism: are we doing a good job?. Gland Surg 2019;8:581–2
  8. Nichols JH, Christtenson RH, Clarke W, Gronowski A, HammettStabler CA, Jacobs E et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Evidence Based Practice for Point of Care Testing. AACC Press; 2006. Available at: https://www.aacc.org/-/media/Files/Science-and-Practice/Practice-Guidelines/Point-of-Care-Testing/POCT-Entire-LMPG.pdf? la=en&hash=FAB661858E6C81B5467B641C99E2EE6BA29D5 0F6. Accessed Apr 12, 2020
  9. Sackett WR, Barraclough B, Reeve TS, Delbridge LW. Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 2002;137:1055–9
  10. Hessman O, Westerdahl J, Al-Suliman N, Christiansen P, Hellman P, Bergenfelz A. Randomized clinical trial comparing open with videoassisted minimally invasive parathyroid surgery for primary hyperparathyroidism. Br J Surg 2010;97:177–84
  11. Roman SA, Sosa JA, Mayes L, Desmond E, Boudourakis L, Lin R, et al. Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery 2005;138:1121–8
  12. Hedbäck G, Tisell LE, Bengtsson BA, Hedman I, Oden A. Premature death in patients operated on for primary hyperparathyroidism. Worl